Search

Issue
Title
Authors
Vol 18, No 1 (2022)
Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer
Avxentyev N.A., Derkach E.V., Makarova Y.V.
PDF
(Rus)
Vol 14, No 4 (2018)
Radionuclide therapy with radium-223 chloride. A few strokes to the patient’s portrait
Oschepkov V.N., Zotov P.B., Ismakov R.M., Khazimov A.M., Tukmanbetov I.D.
PDF
(Rus)
Vol 18, No 2 (2022)
Efficacy of novel androgen axis inhibitors for the treatment of hormone-sensitive prostate cancer in patients with visceral metastases: a systematic review and meta-analysis
Murazov I.G., Prokhorov D.G., Tareev Y.S., Smirnov R.V.
PDF
(Rus)
Vol 14, No 3 (2018)
SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES
Markova A.S., Matveev V.B., Nazranov B.M.
PDF
(Rus)
Vol 16, No 4 (2020)
Efficacy and safety of radium-223 in routine clinical practice
Matveev V.B., Markova A.S.
PDF
(Rus)
Vol 14, No 3 (2018)
NEW TREATMENT STANDARD FOR PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Alekseev B.Y.
PDF
(Rus)
Vol 16, No 2 (2020)
Pharmacoeconomic aspects of using enzalutamide for treatment of patients with nonmetastatic castration-resistant prostate cancer
Avxentyev N.A., Frolov M.Y., Makarova Y.V.
PDF
(Rus) PDF
(Eng)
Vol 14, No 1 (2018)
Safety of enzalutamide in patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy: a phase II, multicenter, single-arm, open-label study
Alekseev B.Y., Matveev V.B., Chkhotua A., Markova A.S.
PDF
(Rus)
Vol 15, No 3 (2019)
New possibilities of combined antiandrogen therapy in patients with metastatic hormone-sensitive prostate cancer
Alekseev B.Y.
PDF
(Rus)
Vol 13, No 4 (2017)
Efficacy and safety of enzalutamide, abiraterone and cabazitaxel in post-docetaxel treatment of castration-resistant prostate cancer: meta-analysis data
Mazin P.V., Mazina N.K.
PDF
(Rus)
Vol 15, No 3 (2019)
The National Registry of treatment regimens in patients with metastatic castration-resistant prostate cancer in the Russian Federation
Karyakin O.B., Kaprin A.D., Ivanov S.A.
PDF
(Rus)
Vol 13, No 3 (2017)
Pharmacoeconomic analysis of enzalutamide and abiraterone for treatment of chemotherapy naive patients with metastatic castration resistant prostate cancer
Avxentyev N.A., Frolov M.Y., Makarov A.S.
PDF
(Rus)
Vol 15, No 2 (2019)
Pharmacoeconomic aspects of using enzalutamide and abiraterone for treatment of chemotherapy-naive patients with metastatic castration-resistant prostate cancer
Avxentyev N.A., Frolov M.Y., Makarova Y.V.
PDF
(Rus)
Vol 11, No 3 (2015)
Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem
Alekseev B.Y.
PDF
(Rus)
Vol 19, No 1 (2023)
Androgen receptor signaling mechanism in prostate cancer: resistance to antiandrogen therapy and association with DNA repair genes
Stukan A.I., Goryainova A.Y., Grigoryan M.M., Kutyan V.F., Zhdanov V.S., Semiglazova T.Y., Imyanitov E.N.
PDF
(Rus)
Vol 14, No 4 (2018)
Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection
Gafanov R.A., Dzidzaria A.G., Kravtsov I.B., Fastovets S.V.
PDF
(Rus)
1 - 16 of 16 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"